Original Research

Business, Original Research

Association Between Formulary Coverage and Use of Abuse-Deterrent Prescription Opioids, Risk for Abuse or Overdose, and Associated Healthcare Resource Utilization

Allison Petrilla, MPH, Elizabeth Marrett, MPH, Xian Shen, PhD, MS, BS, Winghan Jacqueline Kwong, PharmD, PhD, Edmund Pezalla, MD, MPH

Allison Petrilla, MPH; Elizabeth Marrett, MPH; Xian Shen, PhD, MS, BS; Winghan Jacqueline Kwong, PharmD, PhD; Edmund Pezalla, MD, MPH

Stakeholder Perspective

Abuse-Deterrent Formulations of Prescription Opioids: A Missed Opportunity to Address the Current Opioid Crisis?

Atheer A. Kaddis, PharmD

by Atheer A. Kaddis, PharmD

Play Video

Business, Original Research

Budget Impact Analysis of a Home-Based Nutrition Program for Adults at Risk for Malnutrition

Suela Sulo, PhD, MSc, David Lanctin, MPH, Josh Feldstein, BA, Bjoern Schwander, MA, RN, Jamie Partridge, PhD, MBA, Wendy Landow, MPH, York F. Zöllner, MSc

Suela Sulo, PhD, MSc; David Lanctin, MPH; Josh Feldstein, BA; Bjoern Schwander, MA, RN; Jamie Partridge, PhD, MBA; Wendy Landow, MPH; York F. Zöllner, MSc

Play Video

Business, Original Research

Budget Impact Analysis of Using Daunorubicin-Cytarabine Liposome in Patients with Newly Diagnosed Therapy-Related AML or AML and Myelodysplasia-Related Changes

Ivar S. Jensen, MBA, Elizabeth Wu, MPH, Naomi C. Sacks, PhD, Philip L. Cyr, MPH, Karen C. Chung, PharmD, MS

Ivar S. Jensen, MBA; Elizabeth Wu, MPH; Naomi C. Sacks, PhD; Philip L. Cyr, MPH; Karen C. Chung, PharmD, MS

Play Video

Business, Original Research

Budget Impact of a Comprehensive Nutrition-Focused Quality Improvement Program for Malnourished Hospitalized Patients

Suela Sulo, PhD, MSc, Josh Feldstein, BA, Jamie Partridge, PhD, MBA, Bjoern Schwander, MA, RN, Krishnan Sriram, MD, Wm. Thomas Summerfelt, PhD

Suela Sulo, PhD; Josh Feldstein, BA; Jamie Partridge, PhD, MBA; Bjoern Schwander, MS, RN; Krishnan Sriram, MD; Wm. Thomas Summerfelt, PhD

Stakeholder Perspective

The Crucial Role of Nutrition Support Services for Hospitalized Patients

Jack E. Fincham, PhD, RPh

by Jack E. Fincham, PhD, RPh

Play Video

Online First

Business, Original Research

Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer

Neil T. Mason, MBA, Jason M. Burkett, CPA, MACC, Ryan S. Nelson, PharmD, Julio M. Pow-Sang, MD, Robert A. Gatenby, MD, Timothy Kubal, MD, MBA, John W. Peabody, MD, PhD, G. Douglas Letson, MD, Howard L. McLeod, PharmD, Jingsong Zhang, MD, PhD

Neil T. Mason, MBA; Jason M. Burkett, CPA, MACC; Ryan S. Nelson, PharmD; Julio M. Pow-Sang, MD; Robert A. Gatenby, MD; Timothy Kubal, MD, MBA; John W. Peabody, MD, PhD; G. Douglas Letson, MD; Howard L. McLeod, PharmD; Jingsong Zhang, MD, PhD

Play Video

Business, Original Research

Budget Impact of Adding Vedolizumab to a Health Plan Formulary as Another First-Line Biologic Option for Ulcerative Colitis and Crohn’s Disease

Michele Wilson, MSPH, Aaron Lucas, PhD, MPH, Ann Cameron, MA, PhD, Michelle Luo, PhD